British drugmaker AstraZeneca Plc. told Reuters its COVID-19 vaccine should be effective against the new coronavirus variant, adding that studies were under way to fully probe the impact of the mutation.
British drugmaker AstraZeneca Plc. told Reuters its COVID-19 vaccine should be effective against the new coronavirus variant, adding that studies were under way to fully probe the impact of the mutation.